Literature DB >> 23299084

Pharmaceutical and safety considerations of tablet crushing in patients undergoing enteral intubation.

Damien Salmon1, Elisa Pont, Hélène Chevallard, Elhadji Diouf, Mamadou-Lamine Tall, Christine Pivot, Fabrice Pirot.   

Abstract

Medication in patients undergoing enteral intubation addresses various challenging issues considering safety and treatment efficiency. Ideally, other routes of administration (i.e. intravenous or intramuscular routes) or especially dedicated formulations should be used. However, in absence of liquid dosage form, tablets or pills must be crushed and suspended in a vehicle before administration. The administration of oral dosage forms by enteral tube is usually performed by the nursing staff facing (i) pharmaceutical relevance of crushing, (ii) loss and concomitant aero-contamination of drug substance, (iii) drug-nutriment interactions and (iv) enteral feeding tube clogging. In the present study, different combinations of either open or confined crushing and suspending protocols were compared by taking into account the crushing yield, the stability and granulometry of the solid oral form suspension and finally the extend of aerosol contamination during crushing and suspending. All protocols exhibited comparable crushing efficiency and suspending properties, but significantly higher aerosolisation of tablet particles was observed in both open crushing and suspending protocol. Therefore, both confined crushing and suspending protocol constitutes an efficient, time saving and safe alternative to the absence of available liquid dosage form for intubated patients.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299084     DOI: 10.1016/j.ijpharm.2012.12.038

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Development and evaluation of an algorithm to facilitate drug prescription for inpatients with feeding tubes.

Authors:  Kristina Lohmann; Julia Freigofas; Julian Leichsenring; Chantal Marie Wallenwein; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  Eur J Clin Pharmacol       Date:  2015-02-19       Impact factor: 2.953

2.  Inappropriate crushing information on ward lists: cytotoxic drugs, capsules, and modified release formulations are gravely neglected.

Authors:  Kristina Lohmann; Julia Ferber; Alexander Francesco Josef Send; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  Eur J Clin Pharmacol       Date:  2014-01-28       Impact factor: 2.953

3.  Antimicrobial nanocapsules: from new solvent-free process to in vitro efficiency.

Authors:  Julie Steelandt; Damien Salmon; Elodie Gilbert; Eyad Almouazen; François Nr Renaud; Laurène Roussel; Marek Haftek; Fabrice Pirot
Journal:  Int J Nanomedicine       Date:  2014-09-19

Review 4.  Oral drug therapy in elderly with dysphagia: between a rock and a hard place!

Authors:  Serena Logrippo; Giovanna Ricci; Matteo Sestili; Marco Cespi; Letizia Ferrara; Giovanni F Palmieri; Roberta Ganzetti; Giulia Bonacucina; Paolo Blasi
Journal:  Clin Interv Aging       Date:  2017-01-31       Impact factor: 4.458

5.  Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial.

Authors:  Samira Filali; Charlotte Bergamelli; Mamadou Lamine Tall; Damien Salmon; Diane Laleye; Carole Dhelens; Elhadji Diouf; Christine Pivot; Fabrice Pirot
Journal:  J Pharm Anal       Date:  2017-04-06

6.  Medication Errors in Patients with Enteral Feeding Tubes in the Intensive Care Unit.

Authors:  Seyed Mojtaba Sohrevardi; Mohammad Hossein Jarahzadeh; Ehsan Mirzaei; Mahtabalsadat Mirjalili; Arefeh Dehghani Tafti; Behrooz Heydari
Journal:  J Res Pharm Pract       Date:  2017 Apr-Jun

7.  Drug loss while crushing tablets: Comparison of 24 tablet crushing devices.

Authors:  Min Yew Thong; Yady J Manrique; Kathryn J Steadman
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

8.  Rivaroxaban concentrations in acute stroke patients with different dosage forms.

Authors:  Shinichi Wada; Manabu Inoue; Takayuki Matsuki; Takuya Okata; Masaya Kumamoto; Naoki Tagawa; Akira Okamoto; Toshiyuki Miyata; Masafumi Ihara; Masatoshi Koga; Kazunori Toyoda
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

Review 9.  Reducing medication errors in critical care: a multimodal approach.

Authors:  Rachel M Kruer; Andrew S Jarrell; Asad Latif
Journal:  Clin Pharmacol       Date:  2014-09-01

Review 10.  The Added Value of Liquid Antipsychotics: The Case of Quetiapine.

Authors:  Georgios Papazisis; Spyridon Siafis
Journal:  Curr Clin Pharmacol       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.